Repository logo
 

A conserved role of the Hippo signalling pathway in initiation of the first lineage specification event across mammals.

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

McCarthy, Afshan 
Mei Scott, Gwen 
Regin, Marius 
Stamatiadis, Panagiotis  ORCID logo  https://orcid.org/0000-0001-8859-0436

Abstract

Our understanding of the molecular events driving cell specification in early mammalian development relies mainly on mouse studies, and it remains unclear whether these mechanisms are conserved across mammals, including humans. We have shown that the establishment of cell polarity via aPKC is a conserved event in the initiation of the trophectoderm (TE) placental programme in mouse, cow and human embryos. However, the mechanisms transducing cell polarity into cell fate in cow and human embryos are unknown. Here, we have examined the evolutionary conservation of Hippo signalling, which is thought to function downstream of aPKC activity, in four different mammalian species: mouse, rat, cow and human. In all four species, inhibition of the Hippo pathway by targeting LATS kinases is sufficient to drive ectopic TE initiation and downregulation of SOX2. However, the timing and localisation of molecular markers differ across species, with rat embryos more closely recapitulating human and cow developmental dynamics, compared with the mouse. Our comparative embryology approach uncovered intriguing differences as well as similarities in a fundamental developmental process among mammals, reinforcing the importance of cross-species investigations.

Description

Keywords

Comparative embryology, Early development, Hippo signalling pathway, Human, Lineage specification, Placental programme, Cattle, Humans, Female, Pregnancy, Mice, Rats, Animals, Hippo Signaling Pathway, Signal Transduction, Protein Serine-Threonine Kinases, Blastocyst, Placenta, Mammals, Cell Lineage

Journal Title

Development

Conference Name

Journal ISSN

0950-1991
1477-9129

Volume Title

Publisher

The Company of Biologists
Sponsorship
Wellcome Trust (221856/Z/20/Z)